Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death.
Adenoviral vectors are promising tools for pulmonary vascular gene transfer. In first generation vectors, the viral E4 region is preserved (E4+ Ad), but E4 is deleted in second generation vectors (E4- Ad). These vectors were compared for their toxicity in human endothelial cells in terms of apoptosis and necrosis. Infection with E4+ Ad vectors reduced whereas E4- Ad vectors enhanced apoptosis under normal culture conditions. Furthermore, E4+ Ad protected against apoptosis induced by growth factor deprivation, while E4- Ad enhanced apoptosis triggered by ceramide. Ad vectors containing different E4 open reading frames, alone or in different combinations, showed similar effects to E4- Ad, leaving the viral genes that might be responsible for reducing apoptosis unidentified at the present time. As previously observed with E4+ Ad devoid of transgene, E4+ Ad carrying beta-galactosidase or green fluorescent protein under the control of either the RSV or CMV promoter also reduced apoptosis triggered by growth factor deprivation. In contrast, E4+ Ad containing a CFTR expression cassette did not reduce apoptosis, and E4- Ad with CFFR showed increased toxicity. We conclude that Ad vectors may have important effects on the control of apoptosis in transfected cells, depending on the residual expression of viral genes. This effect can be complicated by the action of transgene expression on cell survival.
Jornot
L
L
Respiratory Division, Geneva University Hospitals, Switzerland. Lan.H.Jornot@hcuge.ch
Petersen
H
H
Lusky
M
M
Pavirani
A
A
Moix
I
I
Morris
Rochat
T
T
D000256:Adenoviridae / Q000235:genetics*; D017498:Adenovirus E1 Proteins / Q000235:genetics; D017503:Adenovirus E3 Proteins / Q000235:genetics; D017504:Adenovirus E4 Proteins / Q000235:genetics*; D017456:Adenovirus Early Proteins / Q000235:genetics; D017209:Apoptosis / Q000187:drug effects*; D002518:Ceramides / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects*; D005822:Genetic Vectors / Q000235:genetics / Q000494:pharmacology*; D006133:Growth Substances / Q000494:pharmacology; D006801:Humans; D014161:Transduction, Genetic; D014471:Umbilical Veins
D017498:Adenovirus E1 Proteins; D017503:Adenovirus E3 Proteins; D017504:Adenovirus E4 Proteins; D017456:Adenovirus Early Proteins; D002518:Ceramides; D006133:Growth Substances